Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
although the risk was increased with concomitant SU therapy [11]
For patients taking GLP-1 receptor agonists such as semaglutide or dulaglutide, there is currently no evidence suggesting that allulose interferes with medication efficacy or causes adverse interactions
Growth factor-like peptides, including those derived from natural healing processes, can stimulate cellular repair mechanisms
Because insurance companies view diabetes as an illness, they often cover GLP-agonists to treat it
Supports GLP-1 naturally*
Gavrilova S, Kalyn YB, Safarova T, et al
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
